Literature DB >> 32165250

Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping.

Zhipeng Liu1, Yang Zhang2, Sarah Graham3, Xiaokun Wang2, Defeng Cai4, Menghao Huang5, Roger Pique-Regi6, Xiaocheng Charlie Dong5, Y Eugene Chen3, Cristen Willer7, Wanqing Liu8.   

Abstract

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D) and obesity are epidemiologically correlated with each other but the causal inter-relationships between them remain incompletely understood. We aimed to explore the causal relationships between the 3 diseases.
METHODS: Using both UK Biobank and publicly available genome-wide association study data, we performed a 2-sample bidirectional Mendelian randomization analysis to test the causal inter-relationships between NAFLD, T2D, and obesity. Transgenic mice expressing the human PNPLA3-I148M isoforms (TghPNPLA3-I148M) were used as an example to validate causal effects and explore underlying mechanisms.
RESULTS: Genetically driven NAFLD significantly increased the risk of T2D and central obesity but not insulin resistance or generalized obesity, while genetically driven T2D, body mass index and WHRadjBMI causally increased NAFLD risk. The animal study focusing on PNPLA3 corroborated these causal effects: compared to the TghPNPLA3-I148I controls, the TghPNPLA3-I148M mice developed glucose intolerance and increased visceral fat, but maintained normal insulin sensitivity, reduced body weight, and decreased circulating total cholesterol. Mechanistically, the TghPNPLA3-I148M mice demonstrated decreased pancreatic insulin but increased glucagon secretion, which was associated with increased pancreatic inflammation. In addition, transcription of hepatic cholesterol biosynthesis pathway genes was significantly suppressed, while transcription of thermogenic pathway genes was activated in subcutaneous and brown adipose tissues but not in visceral fat in TghPNPLA3-I148M mice.
CONCLUSIONS: Our study suggests that lifelong, genetically driven NAFLD causally promotes T2D with a late-onset type 1-like diabetic subphenotype and central obesity; while genetically driven T2D, obesity, and central obesity all causally increase the risk of NAFLD. This causal relationship revealed new insights into how nature and nurture drive these diseases, providing novel hypotheses for disease subphenotyping. LAY
SUMMARY: Non-alcoholic fatty liver disease, type 2 diabetes and obesity are epidemiologically correlated with each other, but their causal relationships were incompletely understood. Herein, we identified causal relationships between these conditions, which suggest that each of these closely related diseases should be further stratified into subtypes. This is important for accurate diagnosis, prevention and treatment of these diseases.
Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mendelian randomization; Non-alcoholic fatty liver disease; Obesity; PNPLA3; Type 2 diabetes

Mesh:

Substances:

Year:  2020        PMID: 32165250      PMCID: PMC7371536          DOI: 10.1016/j.jhep.2020.03.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  70 in total

1.  Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment.

Authors:  Jason R Clapper; Michelle D Hendricks; Guibao Gu; Carrie Wittmer; Carrie S Dolman; John Herich; Jennifer Athanacio; Christiane Villescaz; Soumitra S Ghosh; Joseph S Heilig; Carolyn Lowe; Jonathan D Roth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-07-25       Impact factor: 4.052

Review 2.  Immunity-Based Evolutionary Interpretation of Diet-Induced Thermogenesis.

Authors:  Wan-Hui Liao; Maciej Henneberg; Wolfgang Langhans
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

3.  Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach.

Authors:  Paul Welsh; Eliana Polisecki; Michele Robertson; Sabine Jahn; Brendan M Buckley; Anton J M de Craen; Ian Ford; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G J Westendorp; James Shepherd; Aroon D Hingorani; George Davey Smith; Ernst Schaefer; Naveed Sattar
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

4.  Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study.

Authors:  N Maneka G De Silva; Maria Carolina Borges; Aroon D Hingorani; Jorgen Engmann; Tina Shah; Xiaoshuai Zhang; Jian'an Luan; Claudia Langenberg; Andrew Wong; Diana Kuh; John C Chambers; Weihua Zhang; Marjo-Ritta Jarvelin; Sylvain Sebert; Juha Auvinen; Tom R Gaunt; Deborah A Lawlor
Journal:  Diabetes       Date:  2019-05-14       Impact factor: 9.461

5.  Mendelian randomization analysis with multiple genetic variants using summarized data.

Authors:  Stephen Burgess; Adam Butterworth; Simon G Thompson
Journal:  Genet Epidemiol       Date:  2013-09-20       Impact factor: 2.135

6.  Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver.

Authors:  P Dongiovanni; S Stender; A Pietrelli; R M Mancina; A Cespiati; S Petta; S Pelusi; P Pingitore; S Badiali; M Maggioni; V Mannisto; S Grimaudo; R M Pipitone; J Pihlajamaki; A Craxi; M Taube; L M S Carlsson; S Fargion; S Romeo; J Kozlitina; L Valenti
Journal:  J Intern Med       Date:  2017-12-27       Impact factor: 8.989

7.  PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.

Authors:  Yang Wang; Nora Kory; Soumik BasuRay; Jonathan C Cohen; Helen H Hobbs
Journal:  Hepatology       Date:  2019-04-09       Impact factor: 17.425

8.  A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.

Authors:  Alisa K Manning; Marie-France Hivert; Robert A Scott; Jonna L Grimsby; Nabila Bouatia-Naji; Han Chen; Denis Rybin; Ching-Ti Liu; Lawrence F Bielak; Inga Prokopenko; Najaf Amin; Daniel Barnes; Gemma Cadby; Jouke-Jan Hottenga; Erik Ingelsson; Anne U Jackson; Toby Johnson; Stavroula Kanoni; Claes Ladenvall; Vasiliki Lagou; Jari Lahti; Cecile Lecoeur; Yongmei Liu; Maria Teresa Martinez-Larrad; May E Montasser; Pau Navarro; John R B Perry; Laura J Rasmussen-Torvik; Perttu Salo; Naveed Sattar; Dmitry Shungin; Rona J Strawbridge; Toshiko Tanaka; Cornelia M van Duijn; Ping An; Mariza de Andrade; Jeanette S Andrews; Thor Aspelund; Mustafa Atalay; Yurii Aulchenko; Beverley Balkau; Stefania Bandinelli; Jacques S Beckmann; John P Beilby; Claire Bellis; Richard N Bergman; John Blangero; Mladen Boban; Michael Boehnke; Eric Boerwinkle; Lori L Bonnycastle; Dorret I Boomsma; Ingrid B Borecki; Yvonne Böttcher; Claude Bouchard; Eric Brunner; Danijela Budimir; Harry Campbell; Olga Carlson; Peter S Chines; Robert Clarke; Francis S Collins; Arturo Corbatón-Anchuelo; David Couper; Ulf de Faire; George V Dedoussis; Panos Deloukas; Maria Dimitriou; Josephine M Egan; Gudny Eiriksdottir; Michael R Erdos; Johan G Eriksson; Elodie Eury; Luigi Ferrucci; Ian Ford; Nita G Forouhi; Caroline S Fox; Maria Grazia Franzosi; Paul W Franks; Timothy M Frayling; Philippe Froguel; Pilar Galan; Eco de Geus; Bruna Gigante; Nicole L Glazer; Anuj Goel; Leif Groop; Vilmundur Gudnason; Göran Hallmans; Anders Hamsten; Ola Hansson; Tamara B Harris; Caroline Hayward; Simon Heath; Serge Hercberg; Andrew A Hicks; Aroon Hingorani; Albert Hofman; Jennie Hui; Joseph Hung; Marjo-Riitta Jarvelin; Min A Jhun; Paul C D Johnson; J Wouter Jukema; Antti Jula; W H Kao; Jaakko Kaprio; Sharon L R Kardia; Sirkka Keinanen-Kiukaanniemi; Mika Kivimaki; Ivana Kolcic; Peter Kovacs; Meena Kumari; Johanna Kuusisto; Kirsten Ohm Kyvik; Markku Laakso; Timo Lakka; Lars Lannfelt; G Mark Lathrop; Lenore J Launer; Karin Leander; Guo Li; Lars Lind; Jaana Lindstrom; Stéphane Lobbens; Ruth J F Loos; Jian'an Luan; Valeriya Lyssenko; Reedik Mägi; Patrik K E Magnusson; Michael Marmot; Pierre Meneton; Karen L Mohlke; Vincent Mooser; Mario A Morken; Iva Miljkovic; Narisu Narisu; Jeff O'Connell; Ken K Ong; Ben A Oostra; Lyle J Palmer; Aarno Palotie; James S Pankow; John F Peden; Nancy L Pedersen; Marina Pehlic; Leena Peltonen; Brenda Penninx; Marijana Pericic; Markus Perola; Louis Perusse; Patricia A Peyser; Ozren Polasek; Peter P Pramstaller; Michael A Province; Katri Räikkönen; Rainer Rauramaa; Emil Rehnberg; Ken Rice; Jerome I Rotter; Igor Rudan; Aimo Ruokonen; Timo Saaristo; Maria Sabater-Lleal; Veikko Salomaa; David B Savage; Richa Saxena; Peter Schwarz; Udo Seedorf; Bengt Sennblad; Manuel Serrano-Rios; Alan R Shuldiner; Eric J G Sijbrands; David S Siscovick; Johannes H Smit; Kerrin S Small; Nicholas L Smith; Albert Vernon Smith; Alena Stančáková; Kathleen Stirrups; Michael Stumvoll; Yan V Sun; Amy J Swift; Anke Tönjes; Jaakko Tuomilehto; Stella Trompet; Andre G Uitterlinden; Matti Uusitupa; Max Vikström; Veronique Vitart; Marie-Claude Vohl; Benjamin F Voight; Peter Vollenweider; Gerard Waeber; Dawn M Waterworth; Hugh Watkins; Eleanor Wheeler; Elisabeth Widen; Sarah H Wild; Sara M Willems; Gonneke Willemsen; James F Wilson; Jacqueline C M Witteman; Alan F Wright; Hanieh Yaghootkar; Diana Zelenika; Tatijana Zemunik; Lina Zgaga; Nicholas J Wareham; Mark I McCarthy; Ines Barroso; Richard M Watanabe; Jose C Florez; Josée Dupuis; James B Meigs; Claudia Langenberg
Journal:  Nat Genet       Date:  2012-05-13       Impact factor: 38.330

9.  Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge.

Authors:  Richa Saxena; Marie-France Hivert; Claudia Langenberg; Toshiko Tanaka; James S Pankow; Peter Vollenweider; Valeriya Lyssenko; Nabila Bouatia-Naji; Josée Dupuis; Anne U Jackson; W H Linda Kao; Man Li; Nicole L Glazer; Alisa K Manning; Jian'an Luan; Heather M Stringham; Inga Prokopenko; Toby Johnson; Niels Grarup; Trine W Boesgaard; Cécile Lecoeur; Peter Shrader; Jeffrey O'Connell; Erik Ingelsson; David J Couper; Kenneth Rice; Kijoung Song; Camilla H Andreasen; Christian Dina; Anna Köttgen; Olivier Le Bacquer; François Pattou; Jalal Taneera; Valgerdur Steinthorsdottir; Denis Rybin; Kristin Ardlie; Michael Sampson; Lu Qi; Mandy van Hoek; Michael N Weedon; Yurii S Aulchenko; Benjamin F Voight; Harald Grallert; Beverley Balkau; Richard N Bergman; Suzette J Bielinski; Amelie Bonnefond; Lori L Bonnycastle; Knut Borch-Johnsen; Yvonne Böttcher; Eric Brunner; Thomas A Buchanan; Suzannah J Bumpstead; Christine Cavalcanti-Proença; Guillaume Charpentier; Yii-Der Ida Chen; Peter S Chines; Francis S Collins; Marilyn Cornelis; Gabriel J Crawford; Jerome Delplanque; Alex Doney; Josephine M Egan; Michael R Erdos; Mathieu Firmann; Nita G Forouhi; Caroline S Fox; Mark O Goodarzi; Jürgen Graessler; Aroon Hingorani; Bo Isomaa; Torben Jørgensen; Mika Kivimaki; Peter Kovacs; Knut Krohn; Meena Kumari; Torsten Lauritzen; Claire Lévy-Marchal; Vladimir Mayor; Jarred B McAteer; David Meyre; Braxton D Mitchell; Karen L Mohlke; Mario A Morken; Narisu Narisu; Colin N A Palmer; Ruth Pakyz; Laura Pascoe; Felicity Payne; Daniel Pearson; Wolfgang Rathmann; Annelli Sandbaek; Avan Aihie Sayer; Laura J Scott; Stephen J Sharp; Eric Sijbrands; Andrew Singleton; David S Siscovick; Nicholas L Smith; Thomas Sparsø; Amy J Swift; Holly Syddall; Gudmar Thorleifsson; Anke Tönjes; Tiinamaija Tuomi; Jaakko Tuomilehto; Timo T Valle; Gérard Waeber; Andrew Walley; Dawn M Waterworth; Eleftheria Zeggini; Jing Hua Zhao; Thomas Illig; H Erich Wichmann; James F Wilson; Cornelia van Duijn; Frank B Hu; Andrew D Morris; Timothy M Frayling; Andrew T Hattersley; Unnur Thorsteinsdottir; Kari Stefansson; Peter Nilsson; Ann-Christine Syvänen; Alan R Shuldiner; Mark Walker; Stefan R Bornstein; Peter Schwarz; Gordon H Williams; David M Nathan; Johanna Kuusisto; Markku Laakso; Cyrus Cooper; Michael Marmot; Luigi Ferrucci; Vincent Mooser; Michael Stumvoll; Ruth J F Loos; David Altshuler; Bruce M Psaty; Jerome I Rotter; Eric Boerwinkle; Torben Hansen; Oluf Pedersen; Jose C Florez; Mark I McCarthy; Michael Boehnke; Inês Barroso; Robert Sladek; Philippe Froguel; James B Meigs; Leif Groop; Nicholas J Wareham; Richard M Watanabe
Journal:  Nat Genet       Date:  2010-01-17       Impact factor: 38.330

10.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.

Authors:  Jack Bowden; George Davey Smith; Philip C Haycock; Stephen Burgess
Journal:  Genet Epidemiol       Date:  2016-04-07       Impact factor: 2.135

View more
  41 in total

Review 1.  Appraisal of Gene-Environment Interactions in GWAS for Evidence-Based Precision Nutrition Implementation.

Authors:  Rodrigo San-Cristobal; Juan de Toro-Martín; Marie-Claude Vohl
Journal:  Curr Nutr Rep       Date:  2022-08-11

2.  Establishment and validation of a nomogram that predicts the risk of type 2 diabetes in obese patients with non-alcoholic fatty liver disease: a longitudinal observational study.

Authors:  Xintian Cai; Mengru Wang; Shasha Liu; Yujuan Yuan; Junli Hu; Qing Zhu; Jing Hong; Guzailinuer Tuerxun; Huimin Ma; Nanfang Li
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

3.  [TSPAN8 is involved in lipid metabolism in non-alcoholic fatty liver disease in mice].

Authors:  J Zhang; W Xue; S Zhang; Y Zhu; C Yang; Y Gao; L Shi; W Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

4.  Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.

Authors:  Kushala W M Abeysekera; James G Orr; Fiona H Gordon; Laura D Howe; Julian Hamilton-Shield; Jon Heron; Matthew Hickman
Journal:  BMC Gastroenterol       Date:  2022-06-30       Impact factor: 2.847

Review 5.  GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.

Authors:  Dongdong Wang; Emily A Day; Logan K Townsend; Djordje Djordjevic; Sebastian Beck Jørgensen; Gregory R Steinberg
Journal:  Nat Rev Endocrinol       Date:  2021-08-11       Impact factor: 43.330

Review 6.  The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments.

Authors:  Giovanni Targher; Kathleen E Corey; Christopher D Byrne; Michael Roden
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-05-10       Impact factor: 46.802

7.  Improved Functional Causal Likelihood-Based Causal Discovery Method for Diabetes Risk Factors.

Authors:  Xiue Gao; Wenxue Xie; Zumin Wang; Bo Chen; Shengbin Zhou
Journal:  Comput Math Methods Med       Date:  2021-05-14       Impact factor: 2.238

8.  Association between the liver fat score (LFS) and cardiovascular diseases in the national health and nutrition examination survey 1999-2016.

Authors:  Chun-On Lee; Hang-Long Li; Man-Fung Tsoi; Ching-Lung Cheung; Bernard Man Yung Cheung
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

9.  Association of hepatic steatosis derived from ultrasound and quantitative MRI with prediabetes in the general population.

Authors:  Till Ittermann; Henry Völzke; Muhammad Naeem; Robin Bülow; Sabine Schipf; Nicole Werner; Marcus Dörr; Markus M Lerch; Jens-Peter Kühn; Wolfgang Rathmann; Matthias Nauck; Marcello Ricardo Paulista Markus
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

10.  The association between food insulin index and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study.

Authors:  Somaye Fatahi; Mohammad Hassan Sohouli; Appaji Rayi; Farshad Teymoori; Farzad Shidfar
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.